|
Originally published In Press as doi:10.1074/jbc.M005811200 on August 23, 2000
J. Biol. Chem., Vol. 275, Issue 46, 35999-36006, November 17, 2000
An A245T Mutation Conveys on Cytochrome P450eryF the
Ability to Oxidize Alternative Substrates*
Hong
Xiang,
Richard A.
Tschirret-Guth, and
Paul R.
Ortiz de
Montellano
From the Department of Pharmaceutical Chemistry, University of
California, San Francisco, California 94143-0446
Cytochrome P450eryF (CYP107A1),
which hydroxylates deoxyerythronolide B in erythromycin biosynthesis,
lacks the otherwise highly conserved threonine that is thought to
promote O-O bond scission. The role of this threonine is satisfied in
P450eryF by a substrate hydroxyl group, making
deoxyerythronolide B the only acceptable substrate. As shown here,
replacement of Ala245 by a threonine enables the oxidation
of alternative substrates using either H2O2 or
O2/spinach ferredoxin/ferredoxin reductase as the source of
oxidizing equivalents. Testosterone is oxidized to 1-, 11 -, 12-, and
16 -hydroxytestosterone. A kinetic solvent isotope effect of 2.2 indicates that the A245T mutation facilitates dioxygen bond cleavage.
This gain-of-function evidence confirms the role of the conserved
threonine in P450 catalysis. Furthermore, a Hill coefficient of 1.3 and
dependence of the product distribution on the testosterone
concentration suggest that two testosterone molecules bind in the
active site, in accord with a published structure of the
P450eryF-androstenedione complex. P450eryF is thus a structurally defined model for the catalytic turnover of multiply bound substrates proposed to occur with CYP3A4. In view of its
large active site and defined structure, catalytically active
P450eryF mutants are also attractive templates for the engineering of novel P450 activities.
*
This work was supported by National Institutes of Health
Grant GM25515.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: School of Pharmacy,
S-926, University of California, San Francisco, CA 94143-0446. Fax:
415-502-4728; E-mail ortiz@cgl.ucsf.edu.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. D. Sorani, Z. Zador, E. Hurowitz, D. Yan, K. M. Giacomini, and G. T. Manley
Novel variants in human Aquaporin-4 reduce cellular water permeability
Hum. Mol. Genet.,
August 1, 2008;
17(15):
2379 - 2389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. T. Meharenna, K. E. Slessor, S. M. Cavaignac, T. L. Poulos, and J. J. De Voss
The Critical Role of Substrate-Protein Hydrogen Bonding in the Control of Regioselective Hydroxylation in P450cin
J. Biol. Chem.,
April 18, 2008;
283(16):
10804 - 10812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ouellet, L. M. Podust, and P. R. O. de Montellano
Mycobacterium tuberculosis CYP130: CRYSTAL STRUCTURE, BIOPHYSICAL CHARACTERIZATION, AND INTERACTIONS WITH ANTIFUNGAL AZOLE DRUGS
J. Biol. Chem.,
February 22, 2008;
283(8):
5069 - 5080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nagano, J. R. Cupp-Vickery, and T. L. Poulos
Crystal Structures of the Ferrous Dioxygen Complex of Wild-type Cytochrome P450eryF and Its Mutants, A245S and A245T: INVESTIGATION OF THE PROTON TRANSFER SYSTEM IN P450eryF
J. Biol. Chem.,
June 10, 2005;
280(23):
22102 - 22107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Khan, H. Liu, and J. R. Halpert
Homotropic Versus Heterotopic Cooperativity of Cytochrome P450eryF: A Substrate Oxidation and Spectral Titration Study
Drug Metab. Dispos.,
April 1, 2003;
31(4):
356 - 359.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|